OCTN1/SLC22A4 Antibody (892147) [Janelia Fluor® 549]
Novus Biologicals, part of Bio-Techne | Catalog # FAB10985I
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Flow Cytometry
Label
Janelia Fluor 549
Antibody Source
Monoclonal Mouse IgG2A Clone # 892147
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
NS0 mouse myeloma cell line transfected with human SLC22A4
Accession # Q9H015
Accession # Q9H015
Specificity
Detects human OCTN1/SLC22A4 in direct ELISAs.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2A
Applications for OCTN1/SLC22A4 Antibody (892147) [Janelia Fluor® 549]
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: OCTN1/SLC22A4
Long Name
Solute Carrier Family 22 (Organic Cation/Ergothioneine Transporter) Member 4
Alternate Names
ETT, SLC22A4, UT2H
Additional OCTN1/SLC22A4 Products
Product Documents for OCTN1/SLC22A4 Antibody (892147) [Janelia Fluor® 549]
Product Specific Notices for OCTN1/SLC22A4 Antibody (892147) [Janelia Fluor® 549]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...